Folgen
Krishna Kannan
Krishna Kannan
Senior Director, Telesis Bio
Bestätigte E-Mail-Adresse bei telesisbio.com
Titel
Zitiert von
Zitiert von
Jahr
Design and synthesis of a minimal bacterial genome
CA Hutchison III, RY Chuang, VN Noskov, N Assad-Garcia, TJ Deerinck, ...
Science 351 (6280), aad6253, 2016
14372016
Horizontal gene transfer of the algal nuclear gene psbO to the photosynthetic sea slug Elysia chlorotica
ME Rumpho, JM Worful, J Lee, K Kannan, MS Tyler, D Bhattacharya, ...
Proceedings of the National Academy of Sciences 105 (46), 17867-17871, 2008
3022008
The general mode of translation inhibition by macrolide antibiotics
K Kannan, P Kanabar, D Schryer, T Florin, E Oh, N Bahroos, T Tenson, ...
Proceedings of the National Academy of Sciences 111 (45), 15958-15963, 2014
1942014
The key function of a conserved and modified rRNA residue in the ribosomal response to the nascent peptide
N Vázquez‐Laslop, H Ramu, D Klepacki, K Kannan, AS Mankin
The EMBO journal 29 (18), 3108-3117, 2010
1702010
Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel
K Kannan, N Vázquez-Laslop, AS Mankin
Cell 151 (3), 508-520, 2012
1652012
Context-specific inhibition of translation by ribosomal antibiotics targeting the peptidyl transferase center
J Marks, K Kannan, EJ Roncase, D Klepacki, A Kefi, C Orelle, ...
Proceedings of the National Academy of Sciences 113 (43), 12150-12155, 2016
1572016
Macrolide antibiotics in the ribosome exit tunnel: species‐specific binding and action
K Kannan, AS Mankin
Annals of the New York Academy of Sciences 1241 (1), 33-47, 2011
1362011
Digital-to-biological converter for on-demand production of biologics
KS Boles, K Kannan, J Gill, M Felderman, H Gouvis, B Hubby, KI Kamrud, ...
Nature biotechnology 35 (7), 672-675, 2017
922017
Regulation of gene expression by macrolide-induced ribosomal frameshifting
P Gupta, K Kannan, AS Mankin, N Vázquez-Laslop
Molecular cell 52 (5), 629-642, 2013
722013
Cloning, assembly, and modification of the primary human cytomegalovirus isolate Toledo by yeast-based transformation-associated recombination
S Vashee, TB Stockwell, N Alperovich, EA Denisova, DG Gibson, ...
Msphere 2 (5), 10.1128/mspheredirect. 00331-17, 2017
442017
Yeast genome, by design
K Kannan, DG Gibson
Science 355 (6329), 1024-1025, 2017
272017
One step engineering of the small-subunit ribosomal RNA using CRISPR/Cas9
K Kannan, B Tsvetanova, RY Chuang, VN Noskov, N Assad-Garcia, L Ma, ...
Scientific reports 6 (1), 30714, 2016
222016
Design and synthesis of a minimal bacterial genome
EA Strychalski, CA Hutchinson III, RY Chuang, V Noskov, N Assad-Garcia, ...
Elizabeth A. Strychalski, Clyde A. Hutchinson III, Ray-Yuan Chuang, Vladimir …, 2016
132016
Polypeptides with type v crispr activity and uses thereof
RD Monds, SM Mantovani, RS Komor, MC LaFave, K Kannan, ...
US Patent App. 15/953,286, 2018
92018
Tannase activity from the marine cyanobacterium Phormidium valderianum BDU140441
S Palanisami, K Kannan, U Lakshmanan
Journal of applied phycology 24, 1093-1098, 2012
72012
Generation of synthetic genomes
CA Hutchison III, RY Chuang, VN Noskov, BJ Karas, KS Wise, HO Smith, ...
US Patent 11,085,037, 2021
22021
Gross Chromosomal Rearrangements in Kluyveromyces marxianus Revealed by Illumina and Oxford Nanopore Sequencing
L Ding, HD Macdonald, HO Smith, CA Hutchison III, C Merryman, ...
International journal of molecular sciences 21 (19), 7112, 2020
2020
Printing Biologics on Demand
K Kannan, KS Boles, DG Gibson
CELL SYSTEMS 5 (1), 5-5, 2017
2017
Context‐specific action of linezolid and chloramphenicol, the inhibitors of ribosomal peptidyl transferase (752.12)
J Marks, C Orelle, K Kannan, D Klepacki, E Roncase, N Vazquez‐Laslop, ...
The FASEB Journal 28, 752.12, 2014
2014
The Novel Modes of Action of Ribosomal Antibiotics
K Kannan
University of Illinois at Chicago, 2013
2013
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20